Markers and regulators of osteoblast and osteoclast activity in children with X-linked hypophosphatemia treated with burosumab
{{output}}
Burosumab is effective for treatment of rickets in children with X-linked hypophosphatemia (XLH). The effects of burosumab on markers and regulators of osteoblast and osteoclast acitivity are largely unknown. In this cross-sectional observational study, we inv... ...
